Skip to main content
TipRanks
Go Ultimate75% OFF

Diamedica Therapeutics (DMAC) Income Statement

573 Followers

Diamedica Therapeutics Income Statement

Last quarter (Q3 2026), Diamedica Therapeutics's total revenue was $0.00. In Q3, Diamedica Therapeutics's net income was $-11.31M. See Diamedica Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 34.40M$ 26.68M$ 21.27M$ 14.00M$ 13.65M
Depreciation and Amortization$ 43.00K$ 39.00K$ 30.00K$ 25.00K$ 24.00K
$ -32.70M$ -24.38M$ -19.31M$ -13.62M$ -13.54M
$ -34.40M$ -26.68M$ -21.27M$ -14.00M$ -13.65M
$ 1.66M$ 2.27M$ 1.93M$ 353.00K$ 82.00K
$ -32.74M$ -24.41M$ -19.34M$ -13.65M$ -13.56M
$ -32.77M$ -24.44M$ -19.38M$ -13.68M$ -13.59M
Per Share Metrics
Basic EPS$ -0.70$ -0.60$ -0.60$ -0.52$ -0.65
Diluted EPS$ -0.70$ -0.60$ -0.60$ -0.52$ -0.65
Weighted Average Shares Outstanding46.98M40.40M32.57M26.44M20.77M
Weighted Average Shares Outstanding (Diluted)46.98M40.40M32.57M26.44M20.77M

Currency in USD

Diamedica Therapeutics Earnings and Revenue History

-40M-20M020M-1148 %-1147 %-1146 %-1145 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin